FIIs acquire over 1.2 million shares in Sequent Scientific

04 Jun 2014 Evaluate

Several foreign institutional investors acquired over 1.2 million shares in the pharmaceutical and speciality chemicals firm -- Sequent Scientific.

Route One Fund 1 LP has acquired 400,000 shares, Morgan Stanley Asia (Singapore) PTE acquired 408,743 shares and Merrill Lynch Capital Markets Espana SA SV acquired 400,000 shares in the company. The shares were acquired at Rs 250 each.

Meanwhile, Primera Partners PTE has sold 1.29 million shares of Sequent Scientific.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

 

Viyash Scientific Share Price

194.10 -5.30 (-2.66%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×